Navigation Links
Roxane Laboratories, Inc. Initiates a Nationwide Voluntary Recall of Two Manufacturing Lots of Sodium Polystyrene Sulfonate Suspension in the US and Puerto Rico
Date:7/14/2008

COLUMBUS, Ohio, July 14 /PRNewswire/ -- Roxane Laboratories, Inc. announced today that it is conducting a nationwide voluntary recall of two manufacturing lots of Sodium Polystyrene Sulfonate Suspension, USP, 15 g/60 mL Unit dose bottles (NDC 0054-0165-51; Lot 856396A Exp April 2010, and Lot 856693A Exp May 2010). Sodium Polystyrene Sulfonate Suspension is used to treat hyperkalemia (an elevated blood level of the electrolyte potassium).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' number one priority is for the safety of patients who use our products. A sample from product lot 856396A tested positive for a strain of yeast, which could potentially affect immunocompromised patients. Roxane Laboratories believes that this may be attributed to yeast contamination in one lot of high-density polyethylene bottles received from a supplier. There are various manifestations of yeast infections. The risk of developing a yeast infection depends on how immunocompromised the patient is. Additionally, there are a range of symptoms in a yeast infection from thrush, skin rash, and blood infections (sepsis). If patients develop an infection they should consult their physician. Due to the potential risks that could occur in immunocompromised patients, Roxane Laboratories is voluntarily recalling lot 856396A. Although there have been no testing failures associated with lot 856693A, this additional lot is also being included in the recall as a precautionary measure because the same lot of bottles was used in both finished product lots. All other product parameters were within specification and product efficacy is not impacted. There have been no complaints or adverse events reported for the affected lots. This recall is limited to the two lot numbers listed. No other Roxane Laboratories, Inc. products or lots are impacted by this recall. '/>"/>

SOURCE Roxane Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
2. Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
3. Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg
4. Roxane Laboratories, Inc. Announces the Launch of Acarbose Tablets
5. Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules
6. Roxane Laboratories, Inc. Announces the Approval of Morphine Sulfate Tablets and Oral Solution
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
10. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive...and iPod Touch. , Mountai...n,s most popular and addictive game, SplitWords, i...t Words is designed to help banish that ,tip of th...Phone brain game challenges the brain by encourag...
(Date:11/21/2009)... Linwood Group ask whether there is a sec...red? , London, UK (PRWEB)...th up to one in three of the adult UK population d...ing alcohol-related liver disease*, it is hardly a...habilitation programmes and residential centres fo...
(Date:11/20/2009)...HINGTON, Nov. 20 The A... to modify health care reform legislation released...a health insurance individual coverage mandate. Th... mandate will minimize adverse selection stemming ...ribed by the bill. ,, "The individual mandate l...
(Date:11/20/2009)... Senators and Congressmen in Competitive ... Health Care Vote , Washi...d congressmen running for re-election next year in...Charlie Cook, may come to regret voting for House ...ording to a breaking Zogby International/ O’...
(Date:11/20/2009).... LOUIS, Nov. 20 Cente... it will present at the Bank of America Merrill Ly...3, 2009, at the Crowne Plaza Hotel Times Square in...ay, December 2nd at 8:30 a.m. Eastern Time. Invest..., audio webcast of Centene,s presentation at: htt...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
... Applicants for Social Security Di...y; Allsup Answers Common Benefits Questions , ..., 2008 -- People who find themselves with a mental... about a person’s life changes, the past sti...
... Central Bucks Specialists, a lead...s MxSecure, Inc., the nation's leading provid... clinics, as their outsourced medical transcriptio...n's leading provider of medical transcription...
...ne of few trials to recruit large percentage of Af...ipants, PORTLAND, Ore., July 8 Keeping a food di... a study from Kaiser Permanente,s Center,for Healt...ssue of the American Journal of Preventive Medicin...
...ILLS, Calif., July 7 "For several months,senior l...orking on a,settlement agreement with the Californ...ure to all issues relating to previous rescissions...,review our proposal., Following are the key elem...
...uly 7 Ventas, Inc. (NYSE: VTR ),("Ventas" or the... 2008,second quarter earnings release after the cl...ence call to discuss those earnings will be held o...any,s website at http://www.ventasreit.com or at...
... Ill., July 7 The University HealthSystem,Consort... newly created,position of Chief Learning Officer....e in academic internal medicine and comes to UHC f...ingleton was the Petersdorf Scholar in Residence a...
Other Medicine News:Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2
(Date:11/20/2009).... 20 Escalon Medical Cor... its fiscal first quarter ended September 30, 2009...oduct revenue decreased approximately $234,000, or... ended September 30, 2009 as compared to the same ... decreased net revenue of $8,434,000 compared with...
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Pipettes & Pipettors - ...portlinker.com/p0164373/Pipettes--Pipettors---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...gral part of any research laboratory. Large-scale ...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 1Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 2Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 3Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 4Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 5Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 6Breast Cancer Drugs May Fight Cervical Cancer Too 61020 1Breast Cancer Drugs May Fight Cervical Cancer Too 61020 2News from the November December Issue of Molecular Medicine 61017 1News from the November December Issue of Molecular Medicine 61017 2
...VILLE, Md., May 15 Novavax, Inc. (Nasdaq:,NVAX) t... the Phase I/IIa,study of its pandemic influenza v...ects. Favorable interim results from the first pha...70 healthy adult volunteers, were,reported in Dece... vaccine,is well tolerated and immunogenic at the ...
...care Advantage Fee-For-Service Plan Positions Blue...iness, According to a New Report from ...enn., May 15 HealthLeaders-InterStudy, the,leadin...ports that as the,economy continues to stagnate in...ins the best equipped of all of its competitors to...
Other Medicine Technology:Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2
...pose agarose, has been developed for analytical an... separation of high molecular weight DNA [pulsed-f...high gel strength agarose ( 1800 g/cm2, 1%). T...trations of agarose in electrophoretic gels. The a...
Agarose, high gel strength, Molecular Biology Grade
UltraClean™ Forensic Agarose
...se 1000 is specifically formulated for high resolu...This standard melting temperature agarose can reso...ce in size. UltraPure™ Agarose 1000 gels ex...nd improved clarity for enhanced visibility of fra...
Medicine Products: